Delivery Order SPE2DB22D2009-SPE2DB24FL8CH
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $6,385.87 firm fixed price contract is for the supply of the medication Myrbetriq ER 50 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,135.26 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $21,200.33 contract is for the delivery of Myrbetriq ER 50mg tablets to support military treatment programs and facilities. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $25,918.68 firm fixed price delivery order is for the supply of Myrbetriq ER 50 MG tablets. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is for the delivery of Myrbetriq ER 50 mg tablets. The $10,585.83 firm fixed price delivery order has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Myrbetriq ER 50 mg tablets. The contract, valued at $68,843.04, has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $38,308.15, is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,280.59 firm fixed price delivery order is for the supply of 4,563,956,681 units of the drug Myrbetriq ER 50 mg tablets. The order has an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $21,460.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,564,185,904 units of the pharmaceutical product Myrbetriq ER 25 mg tablets, with an ultimate completion date of April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL8CHDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $18,202.77, is for the delivery of Myrbetriq ER 50 mg tablets. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. As a prime contractor, Amerisourcebergen Drug Corp has a long history of providing a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide through its work with DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 2/7/24 |